# OnCo record paper-espac-5-neoadjuvant-borderline-resectable-ghaneh-lancet-gastroenterol-hepatol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-espac-5-neoadjuvant-borderline-resectable-ghaneh-lancet-gastroenterol-hepatol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-espac-5-neoadjuvant-borderline-resectable-ghaneh-lancet-gastroenterol-hepatol-2023" ;
  schema:name "ESPAC-5: immediate surgery versus short-course neoadjuvant chemotherapy or chemoradiotherapy in borderline resectable pancreatic cancer"@en ;
  schema:description "In borderline resectable pancreatic cancer, two months of chemotherapy before surgery did not change how many tumours could be removed but was followed by far better one-year survival than going straight to surgery."@en ;
  schema:url <https://onco.cc/key-papers/paper-espac-5-neoadjuvant-borderline-resectable-ghaneh-lancet-gastroenterol-hepatol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S2468-1253(22)00348-X>, <https://pubmed.ncbi.nlm.nih.gov/36521500/> ;
  schema:sameAs <https://doi.org/10.1016/S2468-1253(22)00348-X> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Ghaneh P, Palmer D, Cicconi S, et al." ;
  onco:cancers <https://onco.cc/cancers/borderline-resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/folfirinox/> ;
  onco:trials <https://onco.cc/trials/espac-5/> .